Company
Headquarters: Taipei, Taiwan
TW$1.58 Billion
TWD as of Jan. 1, 2024
US$51.7 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Sagittarius Life Science Corp researches and develops plant drugs in Taiwan. The company engages in the development of Chinese herbal medicine technology platform for the treatment of various diseases. It also offers nutritional supplements, health foods, and health related products. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Sagittarius Life Science Corp has the following listings and related stock indices.
Stock: TWSE: 3205 wb_incandescent